Scientific resources
Scientific content
Here you can access posters and webinars produced by BioReperia and our partners.
Webinars
All webinars can be accessed through BioReperia´s YouTube channel.
Advancing Prostate Cancer Targeted Therapy: Breaktroughs Using Zebrafish Tumor Xenograft Models.
co-hosted by Mount Sinai
Joining us was Sujit Nair, PhD (Assistant Professor and Director of GU immunotherapy research at the Icahn School of Medicine) and Lasse Jensen, PhD (Senior Associate Professor at Linköping University and CTO at BioReperia) as they discuss their research and answer questions on this topic of using zebrafish as a rapid in vivo model system.
Joining us was Sujit Nair, PhD (Assistant Professor and Director of GU immunotherapy research at the Icahn School of Medicine) and Lasse Jensen, PhD (Senior Associate Professor at Linköping University and CTO at BioReperia) as they discuss their research and answer questions on this topic of using zebrafish as a rapid in vivo model system.
Advancing Human Disease Research with Zebrafish Models: From Tank to Bedside.
co-hosted by In Vivo BioSystems
Joining us was Joseph Bruckner, PhD (Director of Biology at InVivo Biosystems, Oregon) and Gabriela Vazquez Rodriguez , PhD (Project Manager at BioReperia, Sweden) as they discuss their research and answer questions on this topic of using zebrafish as a rapid in vivo model system.
Joining us was Joseph Bruckner, PhD (Director of Biology at InVivo Biosystems, Oregon) and Gabriela Vazquez Rodriguez , PhD (Project Manager at BioReperia, Sweden) as they discuss their research and answer questions on this topic of using zebrafish as a rapid in vivo model system.
Zebrafish Models for Breast Cancer Research: An Immunology Focus.
Joining us were Rispah Torrorey-Sawe, PhD (Senior Lecturer at Moi University, Kenya), and Gabriela Vazquez Rodriguez, PhD (Project Manager at BioReperia), who shared their research and answered questions on aggressive triple-negative breast cancer, with a focus on the higher prevalence of this subtype among Black women.
Extracellular Vesicles in Cancer Research: New opportunities by using Zebrafish tumor xenografts
Joining us were Associate Professor Linda Bojmar, PhD (Linköping University, Sweden), and Associate Professor Lasse Jensen, PhD (Linköping University, Sweden, and CTO & Co-founder of BioReperia), who shared their research and answered questions on this topic.
In vivo zebrafish-based metastatic model for analyzing the effect of novel anti-cancer strategies.
Joining us was associate professor Lasse Jensen, PhD (Linköping University, Sweden and CTO & Co-founder at BioReperia) as they discuss their research and answer questions on this topic.
Zebrafish tumor xenograft models: a prognostic approach to epithelial ovarian cancer.
join Associate Professor (LiU) and BioReperia’s CTO and co-founder Lasse Jensen as we discuss the use of zebrafish embryos and tumor xenografts in ovarian cancer research.
Nordic zebrafish meeting 2024 Poster
EACR 2022 Posters
Zebrafish patient tumor-derived xenograft models as a model for co-clincial development of a novel cancer treatment.
Zebrafish patient tumor-derived xenograft models used for evaluation of check-point inhibitors and autologous T cell activation on primary tumor tissue
In collaboration with NEOGAP therapeutics, Region Östergötland and Karolinska institute
Zebrafish tumor-derived xenograft models for improved diagnosis and treatment planning in ovarian cancer patients
In collaboration with Region Östergötland
AACR 2021 Posters
Zebrafish tumor-derived xenografts established from breast cancer PDX models predict treatment outcome and dissemination risk with superior sensitivity and specificity
In collaboration with Charles River Laboratories
Recapitulating and targeting hypoxia-induced tumor metabolism using zebrafish tumor-derived xenograft models.
In collaboration with Metabomed
AACR 2020 Posters
Zebrafish patient tumor-derived xenograft models synergize with mouse-PDX models for understanding variation in anti-cancer drug responses.
In collaboration with Charles River Laboratories
Zebrafish patient tumor-derived xenograft models used for pre-clinical evaluation of CAN04 for lung and pancreatic cancer.
In collaboration with Cantargia AB and Charles River Laboratories